CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenue
Revenue	$ 69,589	$ 223,679	$ 336,699	$ 425,601
Operating costs and expenses:
Sales and marketing	18,129	5,572	69,268	7,531
Research and development	42,516	9,079	115,303	21,150
General and administrative	25,625	33,084	77,946	56,336
Restructuring charges	137	0	2,020	0
Total operating costs and expenses	137,002	136,304	503,727	258,763
(Loss) income from operations	(67,413)	87,375	(167,028)	166,838
Interest expense	(346)	(1,786)	(413)	(9,752)
Change in fair value of redeemable convertible preferred stock warrants	0	243	0	53
Change in fair value of convertible notes	0	(36,306)	0	(59,560)
Loss on extinguishment of debt	0	0	0	(1,998)
Other income (expense), net	409	(80)	458	(19)
Net (loss) income before income taxes	(67,350)	49,446	(166,983)	95,562
Income tax (benefit) expense	(1,047)	30,098	(4,433)	43,374
Net (loss) income	$ (66,303)	$ 19,348	$ (162,550)	$ 52,188
Net (loss) income per share attributable to common stockholders – basic (in dollars per share)	$ (0.45)	$ 0.14	$ (1.10)	$ 0.37
Weighted-average number of shares used in computation of net (loss) income per share attributable to common stockholders – basic (in shares)	148,285,721	31,554,720	147,443,196	22,997,311
Net (loss) income per share attributable to common stockholders – diluted (in dollars per share)	$ (0.45)	$ 0.13	$ (1.10)	$ 0.35
Weighted-average number of shares used in computation of net (loss) income per share attributable to common stockholders – diluted (in shares)	148,285,721	39,304,978	147,443,196	30,747,569
Product revenue
Revenue
Revenue	$ 66,660	$ 222,594	$ 328,465	$ 424,516
Operating costs and expenses:
Cost of product revenue	50,595	88,569	239,190	173,746
Grant and other revenue
Revenue
Revenue	$ 2,929	$ 1,085	$ 8,234	$ 1,085